Skip to content
  • Sunday, 26 July 2026
  • 2:53 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Discovery of Fam102a as a Dual Regulator in Bone Remodeling Offers New Pathways for Osteoporosis Treatment
Stem Cell & Regenerative Medicine

Discovery of Fam102a as a Dual Regulator in Bone Remodeling Offers New Pathways for Osteoporosis Treatment

Dwi Wanna May 1, 2026 0

In a landmark study that could redefine the clinical approach to metabolic bone diseases, a research team led by Professor…

Read More
Stem Cell & Regenerative Medicine

Inflammatory Remodeling of the Bone Marrow Niche Drives Early Progression of Clonal Hematopoiesis and Myelodysplastic Syndromes

Dwi Wanna May 1, 2026 0

The human bone marrow is one of the most industrious organs in the body, serving as a biological factory that…

Read More
Stem Cell & Regenerative Medicine

Discovery of Fam102a as a Dual Regulator of Bone Remodeling Offers New Horizons for Osteoporosis Treatment

Dwi Wanna Apr 23, 2026 0

In a landmark study that promises to redefine the landscape of musculoskeletal medicine, researchers at the Institute of Science Tokyo…

Read More
Stem Cell & Regenerative Medicine

Inflammatory Remodeling of the Bone Marrow Niche: New Insights into the Early Drivers of Myelodysplastic Syndromes and Clonal Hematopoiesis

Dwi Wanna Apr 16, 2026 0

The human bone marrow is one of the most industrious environments in the human body, functioning as a biological factory…

Read More
Stem Cell & Regenerative Medicine

Discovery of Fam102a as a Dual Regulator of Bone Remodeling Offers New Pathways for Osteoporosis Treatment

Dwi Wanna Apr 16, 2026 0

The intricate balance of the human skeletal system relies on a continuous cycle of renewal known as bone remodeling, a…

Read More
Stem Cell & Regenerative Medicine

Bone Marrow Microenvironment Remodeling Identified as Primary Driver in the Progression of Clonal Hematopoiesis and Myelodysplastic Syndromes

Dwi Wanna Apr 9, 2026 0

The human bone marrow functions as a biological factory of staggering proportions, generating millions of new blood and immune cells…

Read More
Stem Cell & Regenerative Medicine

Discovery of Fam102a Protein as a Dual Regulator of Bone Remodeling Offers New Avenues for Osteoporosis Treatment

Dwi Wanna Mar 31, 2026 0

The landscape of regenerative medicine and orthopedics has been significantly altered by a landmark study identifying a singular protein, family…

Read More
Stem Cell & Regenerative Medicine

Molecular Mapping of Bone Marrow Remodeling Reveals Early Inflammatory Drivers of Blood Cancer and Myelodysplastic Syndrome

Dwi Wanna Mar 25, 2026 0

The human bone marrow is one of the most industrious environments in the human body, a cellular factory that generates…

Read More
Stem Cell & Regenerative Medicine

Identification of Fam102a as a Dual Regulator of Bone Remodeling Offers New Horizons for Osteoporosis Treatment

Dwi Wanna Mar 23, 2026 0

The landscape of regenerative medicine and orthopedics has been significantly advanced by the identification of Family with Sequence Similarity 102…

Read More
Stem Cell & Regenerative Medicine

Inflammatory Remodeling of the Bone Marrow Microenvironment Identified as a Precursor to Myeloid Malignancies

Dwi Wanna Mar 18, 2026 0

The human bone marrow is a site of frantic, precision-engineered biological activity, responsible for the generation of millions of new…

Read More

Posts pagination

1 2
Deloitte Report Reveals Pharma R&D Returns Surge to 7% Driven Primarily by GLP-1 Blockbusters, Raising Sustainability ConcernsScience News: Empowering Public Understanding of Science for Over a CenturyMicroplastic Ingestion and Inhalation Linked to the Acceleration of Neurodegenerative Disorders Through Multiple Biological PathwaysA Coordinated Medical Approach for Cardiovascular-Kidney-Metabolic Syndrome: A New Clinical Guideline
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ